These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3510830)

  • 1. Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts.
    Stein PD; Collins JJ; Kantrowitz A
    Chest; 1986 Feb; 89(2 Suppl):46S-53S. PubMed ID: 3510830
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts.
    Stein PD; Kantrowitz A
    Chest; 1989 Feb; 95(2 Suppl):107S-117S. PubMed ID: 2644093
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic therapy in the coronary vein graft patient.
    Israel DH; Adams PC; Stein B; Chesebro JH; Fuster V
    Clin Cardiol; 1991 Apr; 14(4):283-95. PubMed ID: 2032405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
    Stein PD; Dalen JE; Goldman S; Théroux P
    Chest; 1998 Nov; 114(5 Suppl):658S-665S. PubMed ID: 9822069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Stein PD; Schünemann HJ; Dalen JE; Gutterman D
    Chest; 2004 Sep; 126(3 Suppl):600S-608S. PubMed ID: 15383486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
    Stein PD; Alpert JS; Copeland J; Dalen JE; Goldman S; Turpie AG
    Chest; 1995 Oct; 108(4 Suppl):371S-379S. PubMed ID: 7555190
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends.
    Sun JC; Davidson MJ; Lamy A; Eikelboom JW
    Lancet; 2009 Aug; 374(9689):565-76. PubMed ID: 19683642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
    Stein PD; Dalen JE; Goldman S; Schwartz L; Théroux P; Turpie AG
    Chest; 1995 Oct; 108(4 Suppl):424S-430S. PubMed ID: 7555193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
    Stein PD; Alpert JS; Copeland J; Dalen JE; Goldman S; Turpie AG
    Chest; 1992 Oct; 102(4 Suppl):445S-455S. PubMed ID: 1395828
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
    Mulder BJ; van der Doef RM; van der Wall EE; Tijssen JG; Piek JJ; van der Meer J; Dunning AJ
    Eur Heart J; 1994 Aug; 15(8):1129-34. PubMed ID: 7988607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
    Stein PD; Alpert JS; Dalen JE; Horstkotte D; Turpie AG
    Chest; 1998 Nov; 114(5 Suppl):602S-610S. PubMed ID: 9822066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal antithrombotic therapy for mechanical prosthetic heart valves.
    Chesebro JH; Fuster V
    Circulation; 1996 Nov; 94(9):2055-6. PubMed ID: 8901650
    [No Abstract]   [Full Text] [Related]  

  • 13. [The saphenous vein graft diseases].
    Yavuz T; Kutsal A
    Anadolu Kardiyol Derg; 2002 Mar; 2(1):50-4, AXVII. PubMed ID: 12101795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
    Verstraete M; Brown BG; Chesebro JH; Ekeström S; Harker LA; Henderson AH; Jewitt DE; Oliver MF; Sleight P
    Eur Heart J; 1986 Jan; 7(1):4-13. PubMed ID: 3514223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy in peripheral arterial occlusive disease.
    Jackson MR; Clagett GP
    Chest; 1998 Nov; 114(5 Suppl):666S-682S. PubMed ID: 9822070
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathophysiology of saphenous vein graft failure: a brief overview of interventions.
    Shukla N; Jeremy JY
    Curr Opin Pharmacol; 2012 Apr; 12(2):114-20. PubMed ID: 22321569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate evidence of the benefit of distal protection in vein graft intervention.
    Porto I; Cautilli G; Camaioni C
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):828-9. PubMed ID: 21670703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy for saphenous vein bypass grafts.
    Goodnight SH; Pantley GA; Rahimtoola SH
    Am Heart J; 1980 Oct; 100(4):586-7. PubMed ID: 6968153
    [No Abstract]   [Full Text] [Related]  

  • 19. Embolic protection of saphenous vein graft percutaneous interventions.
    Carter LI; Golzar JA; Cavendish JJ; Dixon SR
    J Interv Cardiol; 2007 Oct; 20(5):351-8. PubMed ID: 17880331
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
    Stein PD; Dalen JE; Goldman S; Theroux P
    Chest; 2001 Jan; 119(1 Suppl):278S-282S. PubMed ID: 11157654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.